Methazolamide-associated temporary leukopenia and thrombocytopenia

A. M. Cohen, M. Prialnik, D. S. Ben-Nissan, H. Savir

Research output: Contribution to journalArticlepeer-review


A three-week course of methazolamide therapy for chronic open-angle glaucoma resulted in marked leukopenia and thrombocytopenia. Prompt discontinuation of therapy resulted in complete recovery of white blood cell and platelet counts within five days. The recommendations for patients receiving carbonic anhydrase inhibitors for blood count control at six-month intervals are discussed.

Original languageEnglish
Pages (from-to)58-59
Number of pages2
JournalDICP, Annals of Pharmacotherapy
Issue number1
StatePublished - 1989
Externally publishedYes


Dive into the research topics of 'Methazolamide-associated temporary leukopenia and thrombocytopenia'. Together they form a unique fingerprint.

Cite this